In an article appearing in ecancermedicalscience, the EORTC’s Emad Shash, Anastassia Negrouk, Sandrine Marreaud, Vassilis Golfinopoulos, Denis Lacombe and Francoise Meunier outline organizational and regulatory constraints for international clinical trials for rare cancers. In an accompanying interview, Dr. Shash offers further insight into this topic.
